Acetic acid, Calcium chloride, Dextrose, Magnesium chloride, Sodium chloride
Acid Concentrate A1230
In other countries
The same active substances on other registers, the same brand first.
- Acid Conc. Haemodialysis KSP-03 (1+44)Saudi Arabia · Kuwait Saudi Pharmaceutical IndustriesSame substance
- Haemodialysis Acid Conc 45XFORMULATON C2Saudi Arabia · Pharmaceutical Solution Industries (PSI)Same substance
- Non Pyrogenic Acid Conc (12-123-005)I.VSaudi Arabia · Arabian Diagnostic and Medical CompanySame substance
Documents
The official texts, at the regulator.
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada · Added 13 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substances
- Acetic acid, Calcium chloride, Dextrose, Magnesium chloride, Sodium chloride
- Strength
- 10.81 G / L + 8.27 G / L + 74.25 G / L + 6.86 G / L + 275 G / L
- Dosage form
- Solution
- Route
- Haemodialysis
- Register
- Canada (Health Canada)
- Status
- Marketed
- Authorised
- 17 Aug 2005
- Registration
- DIN 02254085
- Marketing authorisation holder
- Chief Medical Supplies LTD
- ATC code
- B05ZA
- Supply
- ETHICAL



